News for AlzChem Group AG (ACT.DE)

EQS-News: AlzChem Group AG / Key word(s): Share Buyback/Share Buyback Alzchem Group AG: Disclosure according to Article 5 of...

Increasing demand in sports nutrition, expanding applications in medical settings, and rising awareness among athletes and fitness enthusiasts are the...

EQS-Ad-hoc: AlzChem Group AG / Key word(s): Change in Forecast Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal y...

EQS Voting Rights Announcement: Alzchem Group AG Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of...

EQS-News: Alzchem Group AG / Key word: AGM/EGM Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share...

EQS-Ad-hoc: Alzchem Group AG / Key word: Expansion Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding 15-March-2024 / 17:56 CET/CEST Disclosure of an inside...

Oct 26, 2022 / 08:00AM GMTAndreas Niedermaier - Alzchem Group AG - CEO Good morning [together]. Thank you for joining us today. And welcome to our Q3 analyst ca

Jul 26, 2022 / 08:00AM GMTAndreas Niedermaier - Alzchem Group AG - CEO Good morning [together]. Thank you for joining us today, and welcome to our Q2 analyst ca

Apr 28, 2022 / 08:00AM GMTAndreas Niedermaier - Alzchem Group AG - CEO Good morning [together]. Thank you for joining us today, and welcome to our Q1 analyst ca

May 06, 2021 / 08:00AM GMTAndreas Niedermaier - AlzChem Group AG - CEO Good morning, everybody. Thank you for joining us today and welcome for the Q1 analyst ca